Methods for generating secretory peptides

By using a novel signal peptide to translate and fuse with lactoferrin polypeptide in fungal host cells, the problem of low recombinant protein yield was solved, and a significant increase in lactoferrin yield was achieved.

CN123125334APending Publication Date: 2026-11-17NOVOZYMES AS
View PDF 11 Cites 0 Cited by

Patent Information

Application Number
CN202580028482.8
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Priority Date
2024-04-24
Filing Date
2025-04-21
Publication Date
2026-11-17

AI Technical Summary

Technical Problem

Existing technologies struggle to effectively increase the yield of recombinant proteins such as lactoferrin, especially when expressed in fungal host cells, where difficulties exist in expression, folding, and secretion, and the selection and matching efficiency of signal peptides are hard to predict.

Method used

Nucleic acid constructs and expression vectors were constructed by translating and fusing novel signal peptides (such as the amino acid sequences of SEQ ID NO: 3, 6, 9 and 11 or their variants) with polynucleotides encoding target polypeptides, and then used for expression in fungal host cells to increase yield.

Benefits of technology

Under different fermentation conditions, the yield of lactoferrin was significantly increased, achieving efficient production of recombinant proteins.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure SMS_1
    Figure SMS_1
  • Figure SMS_2
    Figure SMS_2
  • Figure SMS_3
    Figure SMS_3
Patent Text Reader

Abstract

This invention relates to nucleic acid constructs comprising a first polynucleotide encoding a signal peptide and a second polynucleotide encoding a target polypeptide; an expression vector and a host cell comprising the nucleic acid construct; a method for generating the target polypeptide; and a fusion protein comprising the target polypeptide and the signal peptide.
Need to check novelty before this filing date? Find Prior Art

Description

[0001] References to sequence lists

[0002] This application contains a sequence list in computer-readable form, which is incorporated herein by reference. Background of the Invention Technical Field

[0003] This invention relates to nucleic acid constructs comprising a first polynucleotide encoding a signal peptide and a second polynucleotide encoding a target polypeptide; an expression vector and a host cell comprising the nucleic acid construct; a method for generating the target polypeptide; and a fusion protein comprising the target polypeptide and the signal peptide. Background Technology

[0004] Product development in industrial biotechnology faces a persistent challenge: scaling up recombinant protein production to reduce costs. Over the past few decades, two main approaches have been employed for this purpose. The first approach is based on classical mutagenesis and screening. Here, specific gene modifications are not predefined, and the primary requirement is a screening assay sensitive to the incremental yield. High-throughput screening enables the screening of large numbers of mutants to find the desired phenotype, i.e., higher recombinant protein production. The second approach encompasses numerous strategies, ranging from using stronger promoters and multi-copy strains to ensure high expression of the target gene, to using codon-optimized gene sequences to aid translation. However, high levels of production of a given protein can trigger several bottlenecks in cellular mechanisms for the secretion of the target enzyme into the culture medium, highlighting the need for additional optimization strategies.

[0005] Signal peptides (SPs) are short amino acid sequences located at the N-terminus of many newly synthesized peptides. They target these peptides into or across the cell membrane, thereby aiding in maturation and secretion. The amino acid sequence of an SP influences secretion efficiency and, consequently, the yield of peptide manufacturing processes. Bioinformatics tools (such as SignalP and SignalP5) can predict SPs from their amino acid sequences, but most tools cannot distinguish between different types of SPs (Armenteros et al., Nat. Biotechnol. [Nature Biotechnology] 37: 420-423, 2019). Furthermore, the significant redundancy in the amino acid sequences of SPs makes it difficult to predict the efficiency of any given SP for industrial-scale production of recombinant proteins. Currently, there are no tools to predict the efficiency of a given SP in guiding the secretion of a target protein (POI) (Owji et al., Eur. J. Cell Biol. [European Journal of Cell Biology] 2018, 97, 422-441). In fact, the search for efficient SPs for POI secretion remains largely based on trial and error. SP-POI matching has been established to play a crucial role in determining secretion efficiency (Peng, C. et al., Front. Bioeng. Biotechnol. 2019, 7, 139), while the underlying fundamental parameters remain unknown.

[0006] Therefore, SP selection is an important step in the manufacture of recombinant proteins, but the optimal combination of signal peptide and mature protein is highly situation-dependent and not easily predictable.

[0007] While expression systems are available, there remains a need to increase yields during recombinant protein production. Taking recombinant lactoferrin as an example, a significant challenge lies in its multiple disulfide bonds, which make proper expression, folding, and secretion difficult. Therefore, to meet the growing demand for recombinant lactoferrin, it is necessary to provide recombinant expression systems that can increase lactoferrin yield. Summary of the Invention

[0008] This invention is based on the surprising and inventive discovery that the yield of difficult-to-express proteins (e.g., lactoferrin) can be increased when using novel signal peptides in fungal host cells.

[0009] Improved yields of lactoferrin products were observed using the signal peptides of the present invention, for example, using the SP sequences of SEQ ID NO: 3, 6, 9 and 11 (see Tables 1-3).

[0010] It is noteworthy that increased expression was achieved using several different fermentation protocols at different scales, including microtiter plates (MTP), microbioreactors, and glass jar fermentation.

[0011] In a first aspect, the present invention relates to nucleic acid constructs comprising:

[0012] A first polynucleotide encoding a signal peptide, the signal peptide comprising or consisting of: an amino acid sequence having at least 80% sequence identity with any one of the amino acid sequences of SEQ ID NO: 3, 6, 9 or 11; and

[0013] The second polynucleotide encoding the target polypeptide;

[0014] The first polynucleotide and the second polynucleotide are operatively linked by translational fusion, and the first polynucleotide and the second polynucleotide are heterologous to each other.

[0015] In a second aspect, the present invention relates to expression vectors comprising nucleic acid constructs according to the first aspect.

[0016] In a third aspect, the present invention relates to fungal host cells that contain the following in their genome:

[0017] a) Based on the nucleic acid construct of the first aspect, and / or

[0018] b) Based on the expression carrier of the second aspect.

[0019] In a fourth aspect, the present invention relates to methods for generating a target polypeptide, the methods comprising:

[0020] a) Culture host cells according to the third aspect under conditions conducive to the production of the target polypeptide; and optionally...

[0021] b) Recover the target polypeptide.

[0022] In a fifth aspect, the present invention relates to fusion polypeptides comprising:

[0023] A signal peptide comprising or consisting of: an amino acid sequence having at least 60%, for example at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% sequence identity with any of SEQ ID NO: 3, 6, 9, or 11; and

[0024] Lactoferrin polypeptide comprising or composed of the following: an amino acid sequence having at least 60%, for example at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% sequence identity with SEQ ID NO: 13.

[0025] Sequence Overview

[0026] SEQ ID NO:1 is the coding sequence for the TREMBL_U9V5V1 synthetic signal peptide.

[0027] SEQ ID NO:2 is the coding sequence for the TREMBL_U9V5V1_plect_int signal peptide.

[0028] SEQ ID NO:3 is the TREMBL_U9V5V1 signal peptide sequence.

[0029] SEQ ID NO:4 is the coding sequence for the TREMBL_A0A015K2K4 synthetic signal peptide.

[0030] SEQ ID NO:5 is the coding sequence for the TREMBL_A0A015K2K4_plect_int signal peptide.

[0031] SEQ ID NO:6 is the TREMBL_A0A015K2K4 signal peptide sequence.

[0032] SEQ ID NO:7 is the coding sequence for the TREMBL_A0A015IUP6 synthetic signal peptide.

[0033] SEQ ID NO:8 is the coding sequence for the TREMBL_A0A015IUP6_plect_int signal peptide.

[0034] SEQ ID NO:9 is the TREMBL_A0A015IUP6 signal peptide sequence.

[0035] SEQ ID NO:10 is the coding sequence of the AoPlectasinPrePro_SP signal peptide.

[0036] SEQ ID NO:11 is the sequence of the AoPlectasinPrePro_SP signal peptide.

[0037] SEQ ID NO: 12 is the pect_intron encoding sequence.

[0038] SEQ ID NO: 13 is the amino acid sequence of bovine lactoferrin.

[0039] SEQ ID NO: 14 is the bovine lactoferrin DNA sequence.

[0040] definition

[0041] Based on this detailed description, the following definitions apply. Note that the singular forms “a / an” and “the” include plural indicators unless the context explicitly indicates otherwise.

[0042] Unless otherwise defined or explicitly indicated by the context, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention pertains.

[0043] Lactoferrin: The terms “lactoferrin,” “LF,” or “lactoferrin polypeptide” refer to an iron-binding polypeptide, including human lactoferrin and bovine lactoferrin. LF is classified under EC 3.4.21. LF comprises at least three distinct isoforms: (i) LF-α as the iron-binding form, and (ii) LF-β and (iii) LF-γ. Both LF-β and LF-γ are associated with ribonuclease activity (EC 3.1.21.1) and with reduced iron-binding activity or with no iron-binding activity. Furthermore, the term lactoferrin includes whole lactoferrin (iron-rich form) and defatted lactoferrin (iron-free form). LF quantification can be performed as described in the aptamer-based assays in the “Examples” section.

[0044] A non-limiting example of a lactoferrin polypeptide is the bovine lactoferrin polypeptide of SEQ ID NO: 13.

[0045] cDNA: The term "cDNA" refers to a DNA molecule that can be prepared by reverse transcription from mature, spliced ​​mRNA molecules obtained from eukaryotic or prokaryotic cells. cDNA lacks intron sequences that can be present in the corresponding genomic DNA. The initial primary RNA transcript is the precursor of mRNA, which is processed through a series of steps (including splicing) to become mature, spliced ​​mRNA.

[0046] Coding sequence: The term "coding sequence" refers to a polynucleotide that directly specifies the amino acid sequence of a polypeptide. The boundaries of a coding sequence are typically defined by an open reading frame (ORF), which begins with a start codon (such as ATG, GTG, or TTG) and ends with a stop codon (such as TAA, TAG, or TGA). Coding sequences can be genomic DNA, cDNA, synthetic DNA, or a combination thereof.

[0047] Control Sequences: The term "control sequence" refers to a nucleic acid sequence involved in regulating the expression of polynucleotides in a particular organism, either in vivo or in vitro. Each control sequence can be native (i.e., from the same gene) or heterologous (i.e., from different genes) to the polynucleotide encoding a polypeptide, and is native or heterologous relative to each other. Such control sequences include, but are not limited to, leader sequences, polyadenylation sequences, propeptides, signal peptides, promoters, terminators, enhancers, and transcription or translation initiator and terminator sequences. At a minimum, control sequences include promoters and transcription and translation termination signals. These control sequences may be provided with adapters for the purpose of introducing specific restriction sites that facilitate the linking of control sequences to the coding regions of polynucleotides encoding polypeptides.

[0048] Expression: The term “expression” refers to any step involved in polypeptide production, including but not limited to transcription, post-transcriptional modification, translation, post-translational modification, and secretion.

[0049] Expression vector: An expression vector is a linear or circular DNA construct containing a DNA sequence encoding a polypeptide, with the coding sequence operatively linked to a suitable control sequence that can influence the expression of the DNA in a suitable host. Such control sequences may include promoters that affect transcription, optional operon sequences that control transcription, sequences encoding suitable ribosome binding sites on mRNA, enhancers, and sequences that control the termination of transcription and translation.

[0050] Extension: The term "extension" refers to the addition of one or more amino acids to the amino and / or carboxyl termini of a polypeptide, wherein the "extended" polypeptide is a lactoferrin polypeptide with iron-binding capacity. Those skilled in the art will recognize that polypeptides with a given amino acid sequence and enzymatic activity having one or more additional amino acids at the N- and / or C-termini can be generated, and such polypeptides can have substantially the same enzymatic activity. Such extended polypeptides are intended to be covered within the scope of this invention.

[0051] Fragment: When used in the context of a peptide, the term "fragment" refers to a peptide that lacks one or more amino acids at its amino and / or carboxyl termini, wherein the fragment is a lactoferrin fragment with iron-binding capacity. The fragment may arise naturally during peptide expression and / or purification, or it may be the result of expression of a modified nucleotide sequence expressing the fragment, or the result of targeted removal of amino acids from the amino and / or carboxyl termini.

[0052] Fusion polypeptide: The term "fusion polypeptide" is a polypeptide in which one polypeptide is fused to the N-terminus and / or C-terminus of the polypeptide of the present invention. Fusion polypeptides are generated by fusing a polynucleotide encoding another polypeptide with a polynucleotide of the present invention, or by fusing two or more polynucleotides of the present invention together. Techniques for generating fusion polypeptides are known in the art and include linking the coding sequences of the polypeptides such that they conform to reading frames, and that the expression of the fusion polypeptide is under the control of one or more identical promoters and terminators. Fusion polypeptides can also be constructed using intronomer technology, wherein the fusion polypeptide is generated post-translational (Cooper et al., 1993, EMBO J. [Journal of the European Society for Molecular Biology] 12:2575-2583; Dawson et al., 1994, Science [Science] 266: 776-779). Fusion polypeptides may further include a cleavage site between the two polypeptides. This site is cleaved upon secretion of the fusion protein, thereby releasing both polypeptides. Examples of cleavage sites include, but are not limited to, those disclosed in the following literature: Martin et al., 2003, J. Ind. Microbiol. Biotechnol. [Journal of Industrial Microbiology and Biotechnology] 3: 568-576; Svetina et al., 2000, J. Biotechnol. [Journal of Biotechnology] 76: 245-251; Rasmussen-Wilson et al., 1997, Appl. Environ. Microbiol. [Applied and Environmental Microbiology] 63: 3488-3493; Ward et al., 1995, Biotechnology [Biotechnology] 13: 498-503; and Contreras et al., 1991, Biotechnology [Biotechnology] 9: 378-381; Eaton et al., 1986, Biochemistry [Biochemistry] 25: 505-512; Collins-Racie et al., 1995, Biotechnology 13: 982-987; Carter et al., 1989, Proteins: Structure, Function, and Genetics 6: 240-248; and Stevens, 2003, Drug Discovery World 4: 35-48.

[0053] Heterogeneous: For host cells, the term "heterogeneous" means that the polypeptide or nucleic acid is not naturally present in the host cell. For polypeptides or nucleic acids, the term "heterogeneous" means that the control sequence (e.g., promoter) of the polypeptide or nucleic acid is not naturally associated with that polypeptide or nucleic acid; that is, the control sequence comes from a gene other than the gene encoding the mature polypeptide.

[0054] Host strain or host cell: A “host strain” or “host cell” refers to an organism in which an expression vector, bacteriophage, virus, or other DNA construct (including a polynucleotide encoding a target polypeptide, such as an amylase) has been introduced. An exemplary host strain is a microbial cell (e.g., bacteria, filamentous fungi, and yeast) capable of expressing a target polypeptide and / or fermenting sugars. The term “host cell” includes protoplasts produced by cells.

[0055] Introduction: In the context of inserting a nucleic acid sequence into a cell, the term “introduction” means “transfection,” “conversion,” or “transduction,” as is known in the art.

[0056] Isolated: The term "isolated" means a polypeptide, nucleic acid, cell, or other specific material or component that has been separated from at least one other material or component (including, but not limited to, other proteins, nucleic acids, cells, etc.). Therefore, the isolated polypeptide, nucleic acid, cell, or other material exists in a form not found in nature. Isolated polypeptides include, but are not limited to, culture media containing secreted polypeptides expressed in host cells.

[0057] Mature polypeptide: The term "mature polypeptide" refers to a polypeptide in its mature form following translation and any post-translational modifications, such as N-terminal processing (e.g., removal of the signal peptide), C-terminal truncation, glycosylation, phosphorylation, etc.). It is known in the art that host cells can produce mixtures of two or more different mature polypeptides (i.e., with different C-terminal and / or N-terminal amino acids) expressed by the same polynucleotide. It is also known in the art that different host cells process polypeptides differently, and therefore a host cell expressing a polynucleotide can produce different mature polypeptides (e.g., with different C-terminal and / or N-terminal amino acids) compared to another host cell expressing the same polynucleotide. Therefore, due to such differentiated expression by host cells, the mature polypeptides of the present invention may have subtle differences at the N- and / or C-terminus. A mature polypeptide lacking one or more amino acids at the N- and / or C-terminus can be considered a "fragment" of the full-length polypeptide.

[0058] Mature polypeptide coding sequence: The term "mature polypeptide coding sequence" refers to the polynucleotide that encodes the mature lactoferrin polypeptide.

[0059] Natural: The term "natural" refers to nucleic acids or polypeptides that are naturally present in host cells.

[0060] Nucleic acid: The term "nucleic acid" encompasses DNA, RNA, heteroduplexes, and synthetic molecules capable of encoding polypeptides. Nucleic acids can be single-stranded or double-stranded and can be chemically modified. The terms "nucleic acid" and "polynucleotide" are used interchangeably. Because the genetic code is degenerate, more than one codon can be used to encode a specific amino acid, and the compositions and methods of this invention cover nucleotide sequences encoding specific amino acid sequences. Unless otherwise stated, nucleic acid sequences are presented in a 5' to 3' orientation.

[0061] Nucleic acid constructs: The term “nucleic acid construct” refers to a single-stranded or double-stranded nucleic acid molecule that is isolated from a naturally occurring gene or modified in a way that does not originally exist in nature to contain a segment of nucleic acid or is synthesized and contains one or more control sequences that are operatively linked to the nucleic acid sequence.

[0062] Obtained polypeptides / peptides / polynucleotides: When used to refer to polynucleotide sequences, lactoferrin sequences, polypeptide sequences, variant sequences or signal peptide sequences, the terms “obtained” or “derived” mean that the molecule was originally isolated from a given source and that the molecule can be used with its natural sequence, or that the molecule has been modified by methods known to those skilled in the art.

[0063] Operationally linked: The term "operationally linked" means that specified components are in a relationship that allows them to function in the intended manner (including, but not limited to, juxtaposition). For example, a regulatory sequence is operationally linked to a coding sequence such that the expression of the coding sequence is under the control of the regulatory sequence.

[0064] Parent: The term "parent" refers to a polypeptide or lactoferrin polypeptide that acts as a signal peptide, and modifications to it can produce variants of the present invention. The parent can be a naturally occurring (wild-type) polypeptide or a variant or fragment thereof.

[0065] Lactoferrin quantification: For the purposes of this invention, the assay described in the examples is used to quantify lactoferrin.

[0066] Recombination: The term "recombination," used in its conventional sense, refers to the manipulation (e.g., cutting and rejoining) of nucleic acid sequences to form a sequence group different from that found in nature. The term recombination refers to cells, nucleic acids, polypeptides, or vectors that have been modified from their natural state. Thus, for example, recombinant cells express genes not found in their natural (non-recombinant) forms, or express natural genes at different levels or under different conditions compared to those found in nature. The term "recombination" is synonymous with "genetically modified" and "transgenic."

[0067] Sequence identity: The degree of association between two amino acid sequences or two nucleotide sequences is described by the parameter "sequence identity".

[0068] For the purposes of this invention, the Needleman-Wunsch algorithm (Needleman and Wunsch, 1970, J. Mol. Biol. [Journal of Molecular Biology] 48: 443-453) is used to determine the sequence identity between two amino acid sequences as the output of "longest identity". This algorithm is implemented in the Niedel program using the EMBOSS software package (EMBOSS: The European Molecular Biology Open Software Suite, Rice et al., 2000, Trends Genet. [Trends in Genetics] 16: 276-277) (preferably version 6.6.0 or later). The parameters used are a vacancy opening penalty of 10, a vacancy extension penalty of 0.5, and an EBLOSUM62 (EMBOSS version of BLOSUM62) substitution matrix. For the Niedel program to report the longest identity, the non-brief (-nobrief) option must be specified on the command line. The Niedel-marked "longest identity" output is calculated as follows:

[0069] (identical residues × 100) / (alignment length - total number of vacancies in the alignment)

[0070] For the purposes of this invention, the Needleman-Wunsch algorithm (Needleman and Wunsch, 1970, ibid.) is used to determine the sequence identity between two polynucleotide sequences as the output of "longest identity," as implemented by the Niedle program in the EMBOSS software package (EMBOSS: The European Molecular Biology Open Software Suite, Rice et al., 2000, ibid.) (preferably version 6.6.0 or later). The parameters used are a vacancy opening penalty of 10, a vacancy extension penalty of 0.5, and an EDNAFULL (EMBOSS version of NCBINUC 4.4) substitution matrix. For the Niedle program to report the longest identity, the non-simplified option must be specified in the command line. The Niedle-marked "longest identity" output is calculated as follows:

[0071] (Identical deoxyribonucleotides × 100) / (Alignment length – Total number of vacancies in the alignment)

[0072] Signal peptide: A signal peptide is an amino acid sequence that attaches to the N-terminal portion of a protein and promotes its secretion outside the cell. The mature form of extracellular proteins lacks a signal peptide, which is cleaved during the secretion process.

[0073] Subsequence: The term "subsequence" refers to a polynucleotide in which one or more nucleotides are deleted from the 5' and / or 3' end of the coding sequence of a mature polypeptide; wherein the subsequence encodes a fragment having lactoferrin activity.

[0074] Variants: The term "variant" refers to a polypeptide with lactoferrin activity that contains artificial mutations (i.e., substitutions, insertions (including extensions), and / or deletions (e.g., truncations)) at one or more positions. Substitution means replacing an amino acid occupying a position with a different amino acid; deletion means removing an amino acid occupying a position; and insertion means adding 1-5 amino acids (e.g., 1-3 amino acids, especially 1 amino acid) adjacent to and immediately following an amino acid occupying a position.

[0075] Wild-type: When referring to an amino acid or nucleic acid sequence, the term "wild-type" means that the amino acid or nucleic acid sequence is natural or naturally occurring. As used herein, the term "naturally occurring" refers to any substance found in nature (e.g., protein, amino acid, or nucleic acid sequences). Conversely, the term "non-naturally occurring" refers to any substance not found in nature (e.g., recombinant nucleic acid and protein sequences produced in a laboratory, or modifications of wild-type sequences). Detailed Implementation

[0076] This invention is based on the following surprising and inventive discovery: the yield of difficult-to-express proteins (e.g., lactoferrin) can be increased when using the disclosed novel signal peptide in fungal host cells.

[0077] The novel signal peptide of this invention has enabled improved lactoferrin production.

[0078] Polynucleotides

[0079] This invention also relates to polynucleotides encoding the polypeptides of this invention, as described herein.

[0080] The polynucleotide can be genomic DNA, cDNA, synthetic DNA, synthetic RNA, mRNA, or a combination thereof. The polynucleotide can be cloned from strains of the genus *Rhizophagus* (e.g., *Rhizophagus irregularis*) or related organisms, and therefore, for example, can be a polynucleotide sequence encoding a variant of the polypeptide of the present invention.

[0081] In one embodiment, the polynucleotide encoding the signal peptide of the present invention is isolated from Rhizocystis cells, such as Rhizocystis heteromorpha cells.

[0082] The polynucleotide can be cloned from strains of Aspergillus (e.g., Aspergillus oryzae) or related organisms, and thus, for example, can be a polynucleotide sequence encoding a variant of the polypeptide of the present invention.

[0083] In one embodiment, the polynucleotide encoding the signal peptide of the present invention is isolated from Aspergillus cells, such as Aspergillus oryzae cells.

[0084] Polynucleotides can also be mutated by introducing nucleotide substitutions that do not cause changes in the amino acid sequence of the polypeptide but correspond to the codons used by the host organism intended to produce the enzyme, or by introducing nucleotide substitutions that may produce different amino acid sequences. For a general description of nucleotide substitutions, see, for example, Ford et al., 1991, Protein Expression and Purification 2: 95-107.

[0085] On the one hand, polynucleotides are isolated.

[0086] On the other hand, the polynucleotides are purified.

[0087] Nucleic acid constructs

[0088] The present invention also relates to nucleic acid constructs comprising the polynucleotide of the present invention, wherein the polynucleotide is operatively linked to one or more control sequences that, under conditions compatible with these control sequences, guide the expression of the coding sequence in a suitable host cell.

[0089] In a first aspect, the present invention relates to nucleic acid constructs comprising:

[0090] A first polynucleotide encoding a signal peptide, the signal peptide comprising or consisting of: an amino acid sequence having at least 80% sequence identity with any one of the amino acid sequences of SEQ ID NO: 3, 6, 9 or 11; and

[0091] The second polynucleotide encoding the target polypeptide;

[0092] The first polynucleotide and the second polynucleotide are operatively linked by translational fusion, and the first polynucleotide and the second polynucleotide are heterologous to each other.

[0093] In one embodiment, the second polynucleotide is located downstream of the first polynucleotide.

[0094] In one embodiment, the signal peptide is a naturally occurring signal peptide, or a functional fragment or functional variant of a naturally occurring signal peptide.

[0095] In one embodiment, the signal peptide originates from filamentous fungal cells.

[0096] In one embodiment, the first polynucleotide comprises a third polynucleotide.

[0097] In one embodiment, the third polynucleotide is a non-coding intron.

[0098] In one embodiment, the third polynucleotide has at least 80%, such as at least 85%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% sequence identity with SEQ ID NO:12.

[0099] In one embodiment, the nucleic acid construct further includes a heterologous promoter, and wherein the promoter, the first polynucleotide, the second polynucleotide, and optionally the third polynucleotide are operatively linked.

[0100] In one embodiment, the promoter is an amylase promoter, preferably a heterologous promoter is an Aspergillus neutral amylase II promoter, such as the Aspergillus niger neutral amylase II promoter.

[0101] In one embodiment, the promoter is the Aspergillus niger neutral amylase II promoter (Pna2 / tpi) fused with the untranslated leader sequence of Aspergillus niger triphosphate isomerase.

[0102] In one embodiment, the promoter is operatively linked to an mRNA stabilizer region; preferably, the mRNA stabilizer region is a cryIIIA mRNA stabilizer region.

[0103] In one embodiment, the signal peptide is a naturally occurring signal peptide, or a functional fragment or functional variant of a naturally occurring signal peptide.

[0104] In one embodiment, the signal peptide is obtained from a polypeptide expressed by a free Rhizocystis host cell, such as Rhizocystis heteromorpha.

[0105] In one embodiment, the signal peptide is obtained from a polypeptide expressed in a free Aspergillus host cell, such as Aspergillus oryzae.

[0106] In one embodiment, the first polynucleotide encoding the signal peptide comprises or is composed of the following: a polynucleotide having at least 80%, for example at least 85%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% sequence identity with the mature polypeptide encoding sequence of SEQ ID NO: 1; most preferably, the first polynucleotide comprises, is substantially composed of, or is composed of the mature polypeptide encoding sequence of SEQ ID NO: 1.

[0107] In one embodiment, the first polynucleotide encoding the signal peptide comprises or consists of the following: a polynucleotide having at least 80%, for example at least 85%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% sequence identity with the mature polypeptide encoding sequence of SEQ ID NO: 2; most preferably, the first polynucleotide comprises, consists of, or consists of the mature polypeptide encoding sequence of SEQ ID NO: 2.

[0108] In one embodiment, the first polynucleotide encoding the signal peptide comprises or is composed of the following: a polynucleotide having at least 80%, such as at least 85%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% sequence identity with the mature polypeptide encoding sequence of SEQ ID NO: 4; most preferably, the first polynucleotide comprises, is substantially composed of, or is composed of the mature polypeptide encoding sequence of SEQ ID NO: 4.

[0109] In one embodiment, the first polynucleotide encoding the signal peptide comprises or is composed of the following: a polynucleotide having at least 80%, for example at least 85%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% sequence identity with the mature polypeptide encoding sequence of SEQ ID NO: 5; most preferably, the first polynucleotide comprises, is substantially composed of, or is composed of the mature polypeptide encoding sequence of SEQ ID NO: 5.

[0110] In one embodiment, the first polynucleotide encoding the signal peptide comprises or is composed of the following: a polynucleotide having at least 80%, such as at least 85%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% sequence identity with the mature polypeptide encoding sequence of SEQ ID NO: 7; most preferably, the first polynucleotide comprises, is substantially composed of, or is composed of the mature polypeptide encoding sequence of SEQ ID NO: 7.

[0111] In one embodiment, the first polynucleotide encoding the signal peptide comprises or is composed of the following: a polynucleotide having at least 80%, for example at least 85%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% sequence identity with the mature polypeptide coding sequence of SEQ ID NO: 8; most preferably, the first polynucleotide comprises, is substantially composed of, or is composed of the mature polypeptide coding sequence of SEQ ID NO: 8.

[0112] In one embodiment, the first polynucleotide encoding the signal peptide comprises or consists of the following: a polynucleotide having at least 80%, for example at least 85%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% sequence identity with the mature polypeptide encoding sequence of SEQ ID NO: 10; most preferably, the first polynucleotide comprises, is substantially composed of, or consists of the mature polypeptide encoding sequence of SEQ ID NO: 10.

[0113] In one embodiment, the signal peptide is obtained from Rhizocystis cells.

[0114] In one embodiment, the signal peptide is obtained from Heterogeneous Rhizocystis cells.

[0115] In one embodiment, the signal peptide is obtained from Aspergillus cells.

[0116] In one embodiment, the signal peptide is obtained from Aspergillus oryzae cells.

[0117] In one embodiment, the signal peptide comprises or consists of an amino acid sequence having at least 80%, such as at least 85%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% sequence identity with SEQ ID NO: 3.

[0118] In one embodiment, the signal peptide comprises, is substantially composed of, or is composed of SEQ ID NO: 3.

[0119] In one embodiment, the signal peptide comprises or consists of an amino acid sequence having at least 80%, such as at least 85%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% sequence identity with SEQ ID NO: 6.

[0120] In one embodiment, the signal peptide comprises, is substantially composed of, or is composed of SEQ ID NO: 6.

[0121] In one embodiment, the signal peptide comprises or consists of an amino acid sequence having at least 80%, such as at least 85%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% sequence identity with SEQ ID NO: 9.

[0122] In one embodiment, the signal peptide comprises, is substantially composed of, or is composed of SEQ ID NO: 9.

[0123] In one embodiment, the signal peptide comprises or consists of an amino acid sequence having at least 80%, such as at least 85%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% sequence identity with SEQ ID NO: 11.

[0124] In one embodiment, the signal peptide comprises, is substantially composed of, or is composed of SEQ ID NO: 11.

[0125] In one embodiment, the signal peptide consists of an amino acid sequence having or not having a C-terminal alanine of any one of SEQ ID NO: 1, 3, 6, 9 or 11, or a peptide fragment thereof that retains the ability to guide the polypeptide into or across the cell membrane.

[0126] In one embodiment, the N- and / or C-terminus of the signal peptide has been extended by adding one or more amino acids.

[0127] In one embodiment, the signal peptide is a fragment of the signal peptide from any of the foregoing embodiments.

[0128] In one embodiment, the second polynucleotide encoding the target polypeptide has at least 60%, for example, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% sequence identity with the mature polypeptide coding sequence of SEQ ID NO:14; most preferably, the second polynucleotide comprises, is substantially composed of, or is composed of the mature polypeptide coding sequence of SEQ ID NO:14.

[0129] In one embodiment, the target polypeptide is lactoferrin, such as bovine lactoferrin or human lactoferrin.

[0130] In one embodiment, one or more target polypeptides are hydrolases, isomerases, ligases, lyases, oxidoreductases, or transferases, such as α-galactosidase, α-glucosidase, aminopeptidase, amylase, β-galactosidase, β-glucosidase, β-xylosidase, glycosylase, carboxypeptidase, catalase, cellobiase, cellulase, chitinase, keratinase, cyclodextrin glycosyltransferase, deoxyribonuclease, endoglucanase, esterase, glucosylamylase, invertase, laccase, lipase, mannosidase, polysaccharidase, oxidase, pectinase, peroxidase, phytase, polyphenol oxidase, proteolytic enzyme, ribonuclease, transglutaminase, or xylanase.

[0131] In one embodiment, the target polypeptide is bovine lactoferrin.

[0132] In one embodiment, the N- and / or C-terminus of the target polypeptide has been extended by adding one or more amino acids.

[0133] In one embodiment, the target polypeptide is a fragment of the target polypeptide from any of the foregoing embodiments.

[0134] The invention is expected to be equally effective when using signal peptides highly similar to those disclosed in SEQ ID NO: 3, 6, 9, or 11 (encoded by any one of SEQ ID NO: 1, 2, 4, 5, 7, 8, or 10, respectively). For example, one or more non-essential amino acids can be altered. Non-essential amino acids in the signal peptide can be identified according to procedures known in the art, such as site-directed mutagenesis or alanine scanning mutagenesis (Cunningham and Wells, 1989, Science 244: 1081-1085). In the latter technique, a single alanine mutation is introduced at each residue in the molecule, and the signal peptide activity of the resulting molecule is tested to identify amino acid residues and non-essential residues that are crucial to the molecular activity. See also Hilton et al., 1996, J. Biol. Chem. 271: 4699-4708. The identity of essential and non-essential amino acids can also be inferred from comparison with one or more related signal peptides.

[0135] Using known mutagenesis, recombination, and / or tampering methods, followed by relevant screening procedures, one or more amino acid substitutions, deletions, and / or insertions can be made and tested, such as those disclosed by Reidhaar-Olson and Sauer, 1988, Science 241: 53-57; Bowie and Sauer, 1989, Proc. Natl. Acad. Sci. USA 86: 2152-2156; WO 95 / 17413; or WO 95 / 22625. Other methods that can be used include error-prone PCR, phage display (e.g., Lowman et al., 1991, Biochemistry 30: 10832-10837; US Patent No. 5,223,409; WO 92 / 06204), and region-directed mutagenesis (Derbyshire et al., 1986, Gene 46: 145; Ner et al., 1988, DNA 7:127).

[0136] Mutagenesis / recombination methods can be combined with high-throughput, automated screening methods to detect the activity of cloned, mutagenesis-encoded peptides expressed by host cells (Ness et al., 1999, Nature Biotechnology 17: 893-896). Mutagenesis-encoded DNA molecules encoding active peptides can be recovered from host cells and rapidly sequenced using standard methods in the art. These methods allow for the rapid determination of the importance of individual amino acid residues within the peptide.

[0137] In one aspect, the signal peptide is a variant (i.e., a functional variant) or fragment (i.e., a functional fragment) of the signal peptide of any of SEQ ID NO: 3, 6, 9, or 11. In one aspect, the number of changes in the signal peptide variants of the present invention is 1 to 10, for example 1 to 5, such as 1, 2, 3, 4, or 5 changes. Compared with the parent, the changes include substitution, insertion, and / or deletion at one or more (e.g., several) positions. Substitution means replacing an amino acid occupying a position with a different amino acid; deletion means removing an amino acid occupying a position; and insertion means adding an amino acid adjacent to and immediately following the amino acid occupying a position.

[0138] In a preferred embodiment, the signal peptide is a variant of the mature polypeptide of any one of SEQ ID NO: 3, 6, 9 or 11, which contains 1 to 10 changes, such as 1 to 5 changes, like 1, 2, 3, 4 or 5 changes, compared to SEQ ID NO: 3, 6, 9 or 11.

[0139] The first polynucleotide and the second polynucleotide are operably linked in a translationally fusion manner. In the context of this invention, the term "operably linked in a translationally fusion manner" means that a signal peptide encoded by the first polynucleotide and a polypeptide encoded by the second polynucleotide are encoded within the same framework and translated together into a single polypeptide. Preferably, the signal peptide is removed post-translation to provide the desired mature polypeptide. Alternatively, the signal peptide may not be removed or may be partially removed to provide the desired mature polypeptide.

[0140] The first and second polynucleotides can be manipulated in a variety of ways to provide variant expression. Depending on the construct or vector, manipulation of the polynucleotide prior to insertion into the nucleic acid construct or expression vector may be desired or necessary. Techniques for modifying polynucleotides using recombinant DNA methods are well known in the art.

[0141] In addition to the signal peptide, the nucleic acid constructs of the present invention can also be operatively linked to one or more additional control sequences that, under conditions compatible with these control sequences, guide the expression of the coding sequence in a suitable host cell.

[0142] promoter

[0143] The control sequence may be a promoter, i.e., a polynucleotide recognized by the host cell for expressing the polypeptide encoding the present invention. The promoter contains a transcriptional control sequence that mediates polypeptide expression. The promoter can be any polynucleotide exhibiting transcriptional activity in the host cell, including mutant promoters, truncated promoters, and heterozygous promoters, and can be a gene encoding an extracellular or intracellular polypeptide that is homologous or heterologous to the host cell.

[0144] In one embodiment, the nucleic acid construct further includes a heterologous promoter, and wherein the promoter, the first polynucleotide, and the second polynucleotide are operatively linked. The promoter is located upstream of the first polynucleotide.

[0145] In this embodiment, the promoter is a heterogeneous promoter. Preferably, the promoter is a tandem promoter. More preferably, the promoter is a P3 promoter or a P3-based promoter.

[0146] In one embodiment, the promoter is an amylase promoter, preferably a heterologous promoter is an Aspergillus neutral amylase II promoter, such as the Aspergillus niger neutral amylase II promoter.

[0147] In one embodiment, the promoter is the Aspergillus niger neutral amylase II promoter (Pna2 / tpi) fused with the untranslated leader sequence of Aspergillus niger triphosphate isomerase.

[0148] Further suitable promoters for guiding the transcription of the polynucleotides of the present invention in filamentous fungal host cells are promoters obtained from Aspergillus, Fusarium, Rhizomucor and Trichoderma cells, such as promoters described in: Mukherjee et al., 2013, “Trichoderma: Biology and Applications” and Schmoll and Dattenböck, 2016, “Gene Expression Systems in Fungi: Advancements and Applications”, Fungal Biology.

[0149] Examples of useful promoters for expression in yeast hosts are described in: Smolke et al., 2018, “Synthetic Biology: Parts, Devices and Applications” (Chapter 6: Constitutive and Regulated Promoters in Yeast: How to Design and Make Use of Promoters in S. cerevisiae) and Schmoll and Dattenböck, 2016, “Gene Expression Systems in Fungi: Advancements and Applications”, Fungal Biology.

[0150] In one embodiment, the promoter is a promoter operatively linked to the mRNA stabilizer region, such as the P3 promoter. Preferably, the mRNA stabilizer region is the cryIIIA mRNA stabilizer region.

[0151] mRNA stabilizers

[0152] Control sequences can also be mRNA stabilizing regions downstream of the promoter and upstream of the gene's coding sequence, which increase the expression of the gene.

[0153] Examples of suitable mRNA stabilizer regions were obtained from the Bacillus thuringiensis cryIIIA gene (WO 94 / 25612) and the Bacillus subtilis SP82 gene (Hue et al., 1995, Journal of Bacteriology 177: 3465-3471). Examples of fungal mRNA stabilizer regions were described in Geisberg et al., 2014, Cell 156(4): 812-824 and Morozov et al., 2006, Eukaryotic Cell 5(11): 1838-1846.

[0154] Termination

[0155] The control sequence can also be a transcription terminator that is recognized by the host cell to terminate transcription. The terminator is operatively linked to the 3' end of a polynucleotide encoding a polypeptide. Any terminator that is functional in the host cell can be used in this invention.

[0156] Preferred terminators for filamentous fungal host cells can be obtained from Aspergillus or Trichoderma species, such as genes obtained from Aspergillus niger glucosidase, Trichoderma reesei β-glucosidase, Trichoderma reesei cellobiase I, and Trichoderma reesei endoglucanase I, as described in the following terminators: Mukherjee et al., 2013, “Trichoderma: Biology and Applications” and Schmoll and Dattenböck, 2016, “Gene Expression Systems in Fungi: Advancements and Applications”, Fungal Biology.

[0157] Preferred terminators for yeast host cells can be obtained from the genes of Saccharomyces cerevisiae enolase, Saccharomyces cerevisiae cytochrome C (CYC1), and Saccharomyces cerevisiae glyceraldehyde-3-phosphate dehydrogenase. Other useful terminators for yeast host cells are described by Romanos et al., 1992, Yeast [Yeast] 8: 423-488.

[0158] propeptide

[0159] The control sequence can also be a propeptide-coding sequence encoding the propeptide located at the N-terminus of the polypeptide. The resulting polypeptide is called a proenzyme or propeptide progenitor (or, in some cases, a zymogen). The propeptide progenitor is usually inactive and can be converted into an active polypeptide by catalytic cleavage or autocatalytic cleavage of the propeptide progenitor. The propeptide-coding sequence can be obtained from the genes of Bacillus subtilis alkaline protease (aprE), Bacillus subtilis neutral protease (nprT), Myceliophthora thermophila laccase (WO 95 / 33836), Rhizomucor miehei aspartic protease, and Saccharomyces cerevisiae α-factor.

[0160] When both a signal peptide sequence and a propeptide sequence are present, the propeptide sequence is located immediately adjacent to the N-terminus of the polypeptide, and the signal peptide sequence is located immediately adjacent to the N-terminus of the propeptide sequence. Alternatively, when both a signal peptide sequence and a propeptide sequence are present, the polypeptide may contain only a portion of the signal peptide sequence and / or only a portion of the propeptide sequence. Alternatively, the final or isolated polypeptide may comprise a mixture of a mature polypeptide and polypeptides containing partial or full-length propeptide sequences and / or signal peptide sequences.

[0161] Regulation sequence

[0162] It is also desirable to add regulatory sequences that regulate the expression of host cell growth-related peptides. Examples of regulatory sequences are those that cause gene expression to turn on or off in response to chemical or physical stimuli, including the presence of regulatory compounds. In yeast, the ADH2 or GAL1 system can be used. In filamentous fungi, the *Aspergillus niger* glucosylamylase promoter, the *Aspergillus oryzae* TAKA α-amylase promoter and *Aspergillus oryzae* glucosylamylase promoter, the *Trichoderma reesei* cellobiose hydrolase I promoter and the *Trichoderma reesei* cellobiose hydrolase II promoter can be used. Other examples of regulatory sequences are those that allow gene amplification. In fungal systems, these regulatory sequences include dihydrofolate reductase genes amplified in the presence of methotrexate and metallothionein genes amplified with heavy metals.

[0163] Leader sequence

[0164] The control sequence can also be a leader sequence, i.e., an untranslated region of mRNA that is important for translation in the host cell. The leader sequence is operatively linked to the 5' end of a polynucleotide encoding a polypeptide. Any leader sequence that is functional in the host cell can be used.

[0165] Preferred leader sequences for filamentous fungal host cells can be obtained from the genes of Aspergillus oryzae TAKA amylase and Aspergillus nidulans triphosphate isomerase.

[0166] Suitable leader sequences for yeast host cells can be obtained from the following genes: Saccharomyces cerevisiae enolase (ENO-1), Saccharomyces cerevisiae 3-phosphoglycerate kinase, Saccharomyces cerevisiae α-factor, and Saccharomyces cerevisiae alcohol dehydrogenase / glyceraldehyde-3-phosphate dehydrogenase (ADH2 / GAP).

[0167] transcription factors

[0168] Control sequences can also be transcription factors, which are polynucleotides encoding polynucleotide-specific DNA-binding polypeptides that control the rate of transcription of genetic information from DNA to mRNA by binding to specific polynucleotide sequences. Transcription factors can function alone and / or together with one or more other polypeptides or transcription factors in a complex by promoting or blocking the recruitment of RNA polymerase. Transcription factors are characterized by containing at least one DNA-binding domain, which is typically attached to a specific DNA sequence adjacent to the genetic element regulated by the transcription factor. Transcription factors can directly regulate the expression of a target protein, i.e., by binding to their promoter to activate the transcription of the gene encoding the target protein, or indirectly regulate the expression of the target protein, i.e., by binding to the promoter of another transcription factor to activate the transcription of that other transcription factor, which in turn regulates the transcription of the gene encoding the target protein. Suitable transcription factors for prokaryotic host cells are described in Seshasayee et al., Subcell Biochem 2011; 52:7-23, and Balleza et al., FEMS Microbiol Rev 2009, 33(1):133-151.

[0169] polyadenylation sequence

[0170] The control sequence can also be a polyadenylation sequence, i.e., a sequence operatively linked to the 3' end of a polynucleotide that is recognized by the host cell during transcription as a signal to add polyadenylation residues to the transcribed mRNA. Any polyadenylation sequence that is functional in the host cell can be used.

[0171] Preferred polyadenylated sequences for filamentous fungal host cells are obtained from the genes of Aspergillus nidulans anthranilate synthase, Aspergillus niger glucosidase, Aspergillus niger α-glucosidase, Aspergillus oryzae TAKA amylase, and Fusarium oxysporum trypsin-like protease.

[0172] Useful polyadenylation sequences in yeast host cells are described by Guo and Sherman, 1995, Mol. Cellular Biol. [Molecular Cell Biology] 15: 5983-5990.

[0173] expression carrier

[0174] In a second aspect, the invention also relates to recombinant expression vectors comprising a nucleic acid construct according to the first aspect. The expression vector comprises the polynucleotide of the invention, a promoter, and transcription and translation termination signals. Multiple nucleotides and control sequences may be linked together to produce a recombinant expression vector, which may include one or more convenient restriction sites to allow the insertion or substitution of a polynucleotide encoding a polypeptide at such sites. Alternatively, the polynucleotide can be expressed by inserting the polynucleotide or a nucleic acid construct containing the polynucleotide into a suitable vector for expression. In producing the expression vector, the coding sequence is located in the vector such that the coding sequence is operatively linked to a suitable control sequence for expression.

[0175] Recombinant expression vectors can be any vector (e.g., plasmids or viruses) that can readily undergo recombinant DNA procedures and induce polynucleotide expression. The choice of vector will typically depend on its compatibility with the host cell to which it will be introduced. Vectors can be linear or closed circular plasmids.

[0176] The vector can be a self-replicating vector, that is, a vector existing as an extrachromosomal entity whose replication is independent of chromosome replication, such as plasmids, extrachromosomal elements, microchromosomes, or artificial chromosomes. The vector can contain any means to ensure self-replication. Alternatively, the vector can be one that integrates into the genome when introduced into a host cell and replicates along with the chromosome in which it has been integrated. Furthermore, a single vector or plasmid, or two or more vectors or plasmids collectively containing the total DNA of the host cell genome to be introduced, or transposons can be used.

[0177] The vector preferably contains one or more selective markers that allow for convenient selection of cells such as transformed cells, transfected cells, and transduced cells. A selective marker is a gene whose product provides resistance to biocides or viruses, resistance to heavy metals, or prototrophic auxotrophic traits, etc.

[0178] The vector preferably contains one or more elements that allow the vector to be integrated into the genome of the host cell or to enable the vector to replicate autonomously in the cell independently of the genome.

[0179] In order to integrate into the host cell genome, the vector may depend on a polynucleotide sequence encoding a polypeptide or any other element of the vector used for integration into the genome via homologous recombination (such as homologous directed repair (HDR)) or non-homologous recombination (such as non-homologous end joining (NHEJ)).

[0180] For autonomous replication, the vector may further include an origin of replication, which enables the vector to replicate autonomously in the host cell discussed. The origin of replication can be any plasmid replicon that mediates autonomous replication and functions within the cell. The terms "origin of replication" or "plasmid replicon" refer to the polynucleotide that enables a plasmid or vector to replicate in vivo.

[0181] More than one copy of the polynucleotide of the present invention can be inserted into host cells to enhance polypeptide production. For example, two, three, four, five, or more copies can be inserted into host cells. An increased copy number of the polynucleotide can be obtained by integrating at least one additional copy of the sequence into the host cell genome or by including an amplifiable selective marker gene along with the polynucleotide, wherein cells containing the amplified copy of the selective marker gene and thus additional copies of the polynucleotide can be selected by culturing cells in the presence of a suitable selective agent.

[0182] host cells

[0183] In a third aspect, the present invention relates to fungal host cells that contain the following in their genome:

[0184] a) Based on the nucleic acid construct of the first aspect; and / or

[0185] b) Based on the expression carrier of the second aspect.

[0186] A construct or vector containing a polynucleotide is introduced into a host cell, such that the construct or vector is maintained as a chromosomal integrase or as a self-replicating extrachromosomal vector, as previously described. The choice of host cell will depend largely on the gene encoding the polypeptide and its origin. The polypeptide encoded by the introduced polynucleotide can be native or heterologous to the recombinant host cell. Furthermore, at least one of one or more control sequences can be heterologous to the polynucleotide encoding the polypeptide. The recombinant host cell can contain a single copy or at least two copies, such as three, four, five, or more copies of the polynucleotide of the present invention.

[0187] In one embodiment, the host cell contains two or more copies of the nucleic acid construct and / or expression vector.

[0188] The host cell can be a fungal cell. As used herein, “fungus” includes Ascomycota, Basidiomycota, Chytridiomycota, Zygomycota, Oomycota, and all mitotic fungi (as defined by Hawksworth et al. in Ainsworth and Bisby’s Dictionary of The Fungi, 8th edition, 1995, CAB International, University Press, Cambridge, UK).

[0189] Fungal cells can be transformed via processes involving protoplast-mediated transformation, Agrobacterium-mediated transformation, electroporation, gene gun methods, and shock wave-mediated transformation (as reviewed in Li et al., 2017, Microbial Cell Factories, 16: 168), as well as procedures described in EP 238023, Yelton et al., 1984, Proc. Natl. Acad. Sci. USA, 81: 1470-1474; Christensen et al., 1988, Bio / Technology, 6: 1419-1422; and Lubertozzi and Keasling, 2009, Biotechn. Advances, 27: 53-75. However, any method known in the art for introducing DNA into fungal host cells can be used, and the DNA can be introduced as linearized or circular polynucleotides.

[0190] The host cell for fungi can be a yeast cell. As used herein, “yeast” includes ascosporogenous yeast (Endomycetales), basidiosporogenous yeast, and yeasts belonging to the class Fungi Imperfecti (Blastomycetes). For the purposes of this invention, yeast should be defined as described in Biology and Activities of Yeast (edited by Skinner, Passmore, and Davenport, Soc. App. Bacteriol. Symposium Series No. 9, 1980).

[0191] Yeast host cells can be cells from the genera *Candida*, *Hansenula*, *Kluyveromyces*, *Pichia*, *Saccharomyces*, *Schizosaccharomyces*, or *Yarrowia*, such as *Kluyveromyces lactis*, *Saccharomyces carlsbergensis*, *Saccharomyces diastaticus*, *Saccharomyces douglasii*, *Saccharomyces kluyveri*, *Saccharomyces norbensis*, *Saccharomyces oviformis*, or *Yarrowia lipolytica*. In a preferred embodiment, the yeast host cell is a cell of the genera *Pichia* or *Komagataella*, such as *Pichia pastoris* cells (*Komagataella phaffii*).

[0192] The host cell for fungi can be a filamentous fungal cell. "Filamentous fungi" includes all filamentous forms within the phylum Eumycota and the subphylum Oomycetes (as defined by Hawksworth et al., 1995, ibid.). Filamentous fungi are generally characterized by a hyphal wall composed of chitin, cellulose, glucan, chitosan, mannan, and other complex polysaccharides. Vegetative growth occurs through hyphal elongation, and carbon metabolism is obligate aerobic. In contrast, the vegetative growth of yeasts (such as Saccharomyces cerevisiae) occurs through budding of single-celled cells, and carbon metabolism can be fermentative.

[0193] The host cells of filamentous fungi can be *Acremonium*, *Aspergillus*, *Aureobasidium*, *Bjerkandera*, *Ceriporiopsis*, *Chrysosporium*, *Coprinus*, *Coriolus*, *Cryptococcus*, *Filibasidium*, *Fusarium*, *Humicola*, *Magnaporthe*, *Mucor*, *Myceliophthora*, and *Neurospora*. Cells of the genera *Neocallimastix*, *Neurospora*, *Paecilomyces*, *Penicillium*, *Phanerochaete*, *Phlebia*, *Piromyces*, *Pleurotus*, *Schizophyllum*, *Talaromyces*, *Thermoascus*, *Thielavia*, *Tolypocladium*, *Trametes*, or *Trichoderma* are used. In a preferred embodiment, the filamentous fungal host cells are *Aspergillus*, *Trichoderma*, or *Fusarium* cells. In another preferred embodiment, the filamentous fungal host cells are *Aspergillus niger*, *Aspergillus oryzae*, *Trichoderma reesei*, or *Fusarium venenatum* cells.

[0194] For example, the host cells of filamentous fungi can be *Aspergillus awamori*, *Aspergillus foetidus*, *Aspergillus fumigatus*, *Aspergillus japonicus*, *Aspergillus nidus*, *Aspergillus niger*, *Aspergillus oryzae*, *Bjerkandera adusta*, *Ceriporiopsis aneirina*, *Ceriporiopsis caregiea*, *Ceriporiopsis gilvescens*, *Ceriporiopsis pannocinta*, *Ceriporiopsis rivulosa*, *Ceriporiopsis subrufa*, *Ceriporiopsis subvermispora*, *Chrysosporium inops*, and *Chrysosporium horneri*. *Chrysosporium lucknowense*, *Chrysosporium merdarium*, *Chrysosporium pannicola*, *Chrysosporium queenslandicum*, *Chrysosporium tropicum*, *Chrysosporium zonatum*, *Coprinus cinereus*, *Coriolus hirsutus*, *Fusarium bactridioides*, *Fusarium cerealis*, *Fusarium crookwellense*, *Fusarium culmorum*, *Fusarium graminearum*, *Fusarium graminum*, *Fusarium heterosporum*, *Fusarium scabra* Fusarium oxysporum, Fusarium reticulatum, Fusarium roseum, Fusarium sambucinum, Fusarium peltataFusarium sarcochroum, Fusarium sporotrichioides, Fusarium sulphureum, Fusarium torulosum, Fusarium trichothecioides, Fusarium spp., Humicola insolens, Humicola lanuginosa, Mucor miehei, Myceliophthora thermophila, Neurospora crassa, Penicillium purpurogenum, Phanerochaete chrysosporium, Phlebia radiata, Pleurotus eryngii, Talaromyces emersonii, Thievaria terrestris, Trametes Trichoderma villosa, Trametes versicolor, Trichoderma harzianum, Trichoderma koningii, Trichoderma longibrachiatum, Trichoderma reesei, or Trichoderma viride cells.

[0195] In one embodiment, the host cell is an Aspergillus cell.

[0196] In another embodiment, the host cell is an Aspergillus niger cell.

[0197] In one embodiment, the host cell is an Aspergillus oryzae cell.

[0198] On the one hand, the host cell is isolated.

[0199] In one embodiment, the host cell contains at least two copies of the nucleic acid construct and / or expression vector, such as two copies, three copies, four copies, or more than four copies.

[0200] On the other hand, the host cell is purified.

[0201] Generation method

[0202] In a fourth aspect, the present invention also relates to methods for generating target polypeptides, the methods comprising:

[0203] a) Culture host cells according to the third aspect under conditions conducive to the production of the target polypeptide; and optionally...

[0204] b) Recover the target polypeptide.

[0205] The host cells are cultured in a nutrient medium suitable for producing peptides using methods known in the art. For example, cells can be cultured in a suitable medium and under conditions that allow for peptide expression and / or isolation by shake-flask culture or by small-scale or large-scale fermentation (including continuous, batch, fed-batch, or solid-state and / or microcarrier-based fermentation) in a laboratory or industrial fermenter. Suitable media are available from commercial suppliers or can be prepared according to publicly available compositions (e.g., in the catalogue of the U.S. Center for Type Culture Collection). If the peptide is secreted into the nutrient medium, it can be recovered directly from that medium. If the peptide is not secreted, it can be recovered from cell lysates.

[0206] Peptides can be detected using methods known in the art that are specific to peptides, including but not limited to the use of specific antibodies, enzyme product formation, enzyme substrate disappearance, or determination of the relative or specific activity of the peptide.

[0207] Peptides can be recovered from culture media using methods known in the art, including but not limited to collection, centrifugation, filtration, extraction, spray drying, evaporation, or precipitation. In one aspect, whole fermentation broth containing peptides is recovered. In another aspect, cell-free fermentation broth containing peptides is recovered.

[0208] Peptides can be purified using a variety of procedures known in the art to obtain substantially pure peptides and / or peptide fragments (see, for example, Wingfield, 2015, Current Protocols in Protein Science; 80(1): 6.1.1-6.1.35; Labrou, 2014, Protein Downstream Processing, 1129: 3-10).

[0209] Alternatively, the target polypeptide is not recycled. In one aspect, instead of recycling the target polypeptide, the host cell of the present invention expressing the target polypeptide is used as a source of variant.

[0210] Fusion Peptides

[0211] In a fifth aspect, the present invention relates to a fusion polypeptide comprising...

[0212] a) A signal peptide comprising or consisting of: an amino acid sequence having at least 60% sequence identity with any one of SEQ ID NO: 3, 6, 9 or 11, and

[0213] b) A lactoferrin polypeptide comprising or consisting of an amino acid sequence having at least 60% sequence identity with SEQ ID NO: 13.

[0214] In one embodiment, the target polypeptide comprises a lactoferrin polypeptide containing, or consisting of, an amino acid sequence having at least 60% sequence identity with SEQ ID NO: 13.

[0215] In one embodiment, the signal peptide is located upstream of the target polypeptide.

[0216] In one embodiment, the signal peptide is located at the N-terminus of the target polypeptide.

[0217] In one embodiment, the lactoferrin polypeptide is selected from the group consisting of:

[0218] (a) A polypeptide having at least 60% sequence identity with SEQ ID NO: 13;

[0219] (b) A polypeptide encoded by a polynucleotide having at least 60% sequence identity with the mature polypeptide encoding sequence of SEQ ID NO: 14;

[0220] (c) A polypeptide derived from SEQ ID NO: 13 by having 1 to 30 alterations (e.g., substitution, deletion and / or insertion) at one or more locations, such as 1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 or 9 or 10 or 11 or 12 or 13 or 14 or 15 or 16 or 17 or 18 or 19 or 20 or 21 or 22 or 23 or 24 or 25 or 26 or 27 or 28 or 29 or 30 alterations, particularly substitutions;

[0221] (d) A polypeptide derived from (a), (b) or (c) wherein the N-terminus and / or C-terminus have been extended by adding one or more amino acids;

[0222] Fragments of polypeptides of (e), (a), (b), (c), or (d), and

[0223] (f)(e) fragments, wherein the polypeptide has 1-10 deletions at the N-terminus.

[0224] Fermentation broth preparations or cell compositions

[0225] The present invention also relates to fermentation broth formulations or cell compositions comprising the target polypeptide, such as fusion proteins according to the fifth aspect and / or cells according to the third aspect. The fermentation broth product further comprises additional components used in the fermentation process, such as, for example, cells (including host cells containing the nucleic acid constructs of the present invention, these host cells being used to produce polypeptides with phytase activity), cell debris, biomass, fermentation medium, and / or fermentation products. In some embodiments, the composition is a cell-killing whole culture medium containing organic acids, killed cells and / or cell debris, and a culture medium.

[0226] As used herein, the term "fermentation broth" refers to a preparation produced by cell fermentation that undergoes little or no recovery and / or purification. For example, fermentation broth is produced when a microbial culture is grown to saturation, incubated under carbon-limited conditions to allow protein synthesis (e.g., enzyme expression by the host cell), and secreted into a cell culture medium. Fermentation broth may contain ungraded or graded contents of fermentation material derived at the end of fermentation. Typically, fermentation broth is ungraded and contains used culture medium and cell debris remaining after, for example, removal of microbial cells (e.g., filamentous fungal cells) by centrifugation. In some embodiments, fermentation broth contains used cell culture medium, extracellular enzymes, and viable and / or non-viable microbial cells.

[0227] In some embodiments, the fermentation broth formulation or cell composition comprises a first organic acid component (an organic acid containing at least one to five carbons and / or its salt) and a second organic acid component (an organic acid containing at least six or more carbons and / or its salt). In some embodiments, the first organic acid component is acetic acid, formic acid, propionic acid, its salt, or a mixture of two or more of the foregoing; and the second organic acid component is benzoic acid, cyclohexanecarboxylic acid, 4-methylvaleric acid, phenylacetic acid, its salt, or a mixture of two or more of the foregoing.

[0228] In one aspect, the composition contains one or more organic acids and optionally further contains killed cells and / or cell debris. In some embodiments, these killed cells and / or cell debris are removed from the cell-killing whole culture medium to provide a composition free of these components.

[0229] Fermentation broth formulations or cell compositions may further contain preservatives and / or antimicrobial (e.g., bacteriostatic) agents, including but not limited to sorbitol, sodium chloride, potassium sorbate, and other agents known in the art.

[0230] The cell-killing whole culture or cell composition may contain ungraded contents of fermentation material derived at the end of fermentation. Typically, the cell-killing whole culture or cell composition contains used culture medium and cell debris present after microbial cells (e.g., filamentous fungal cells) have been grown to saturation and incubated under carbon-limited conditions to allow protein synthesis. In some embodiments, the cell-killing whole culture or cell composition contains used cell culture medium, extracellular enzymes, and killed filamentous fungal cells. In some embodiments, methods known in the art can be used to permeate and / or lyse the microbial cells present in the cell-killing whole culture or composition.

[0231] The whole culture medium or cell composition described herein is typically a liquid, but may contain insoluble components such as killed cells, cell debris, culture medium components, and / or one or more insoluble enzymes. In some embodiments, insoluble components may be removed to provide a clear liquid composition.

[0232] The whole culture medium formulations and cell compositions of the present invention can be produced by the methods described in WO 90 / 15861 or WO 2010 / 096673.

[0233] The invention is further described by the following examples, which should not be construed as limiting the scope of the invention.

[0234] Example

[0235] Example 1: Signal peptide library for expressing bovine lactoferrin

[0236] Signal peptide constructs for expressing bovine lactoferrin (bLF) (SEQ ID NO: 13) were prepared using a single-pool transformation method. 285 different signal peptides were ordered as a single pool and amplified by PCR. The signal peptides were designed in two forms: with or without the intron shown in SEQ ID NO: 12. For the expression cassette, three fragments were prepared and transformed into *Aspergillus oryzae* using a direct-overlay recombination system via homologous recombination. The first fragment contained a portion of the niaD locus. The second fragment consisted of a pooled signal peptide with ends homologous to the first and third fragments, respectively. The third fragment consisted of a portion of the bovine lactoferrin gene and the niiA locus. During transformation (*Aspergillus oryzae* host COLS1300), the bLF expression cassette was integrated along with the amplified signal peptide pool using a CRISPR system. We used the *Aspergillus niger* neutral amylase II promoter (Pna2 / tpi) fused to the non-translational leader sequence of *Aspergillus niger* triose phosphate isomerase. Transformants grown on the selection plate were merged, and spores were sorted into individual wells of 32 96-well plates using FACS, resulting in approximately 2816 independent transformants per spore. The strains produced using this method contained a single copy of the expression cassette in their genome, confirmed by amplicon sequencing.

[0237] Example 2: Signal peptides showing bovine lactoferrin expression

[0238] We screened all 2816 strains for bovine lactoferrin production using MTP. The strains were cultured in expression medium for 4 days. The supernatant of the samples was filtered, and bovine lactoferrin was quantified using an aptamer-based assay that yielded millipolarization values ​​corresponding to bovine lactoferrin expression. As shown in Table 1, we obtained 6 strains exhibiting high millipolarization values, which were correlated with bovine lactoferrin expression. Notably, quantification of lactoferrin using the native lactoferrin signal peptide was not possible (data not shown).

[0239] As shown in Table 1, lactoferrin expression does not directly depend on the absence or presence of the intron with SEQ ID NO: 12.

[0240] Table 1. Millipolarization values ​​of signal peptides expressing bovine lactoferrin in Aspergillus oryzae.

[0241]

[0242] Example 3: Confirmation of bovine lactoferrin expression during glass jar fermentation

[0243] One copy of the strain showing bovine lactoferrin expression in an MTP assay was selected for fermentation in glass jars under current optimized conditions. Bovine lactoferrin expression using the selected signal peptide was compared with the signal peptide of SEQ ID NO: 9. Another signal peptide (SEQ ID NO: 11) encoded by SEQ ID NO: 10, cloned according to Example 1 and containing the intron of SEQ ID NO: 12, was added to the experiment.

[0244] Bovine lactoferrin expression was quantified using Labchip. As shown in Table 2, bLF expression was achieved for all four selected signal peptide (SP) sequences. Among the SP sequences for the four tests, the SP with SEQ ID NO: 3 (without intron sequence) achieved the highest bLF expression. SP sequences SEQ ID NO: 6 (without intron) and SEQ ID NO: 11 (with intron) achieved similarly high bLF expression yields.

[0245] Table 2. Relative bLF expression in glass jars using different signal peptides.

[0246]

[0247] Example 4: Increased bLF production in a microbioreactor

[0248] A multi-copy strain of *Aspergillus oryzae* was constructed from a parental strain containing the IreA mutation described in WO 2018 / 015443 A1. The expression cassette was integrated into the strain genome using the method described in WO 2013 / 178674.

[0249] These strains expressed bLF using either the SP of SEQ ID NO:9 (encoded by SEQ ID NO:7) or the SP of SEQ ID NO:11 (encoded by SEQ ID NO:10), and these strains contained 2 or 3 copies of the expression cassette (see Table 3). The strains were cultured in microbioreactors at a volume of 250 ml per reactor. After 7 days of culture, bLF yield was measured using LabChip® (Revvity), and the results are shown in Table 3. The bLF yields in Table 3 are normalized relative to the bLF yields of strains containing the SP of SEQ ID NO:11. Furthermore, the bLF yields for each strain were normalized relative to the copy number of the expression vector. As shown in Table 3, for multi-copy strains, the SP of SEQ ID NO:9 showed a 69%–75% increase in bLF yield compared to the strain containing the SP of SEQ ID NO:11.

[0250] Table 3. Relative bLF expression in microbioreactors using different signal peptides.

[0251]

[0252] Materials and Methods

[0253] Routine PCR was performed using standard molecular biology methods as described below: Sambrook et al. (1989), *Molecular Cloning: A Laboratory Manual*, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY; Ausubel, FM et al. (eds.), “Current protocols in Molecular Biology”, John Wiley and Sons, 1995; Harwood, CR., and Cutting, SM. (eds.), “Molecular Biological Methods for Bacillus”, John Wiley and Sons, 1990.

[0254] culture medium

[0255] The COVE trace metal solution consists of the following: 0.04 g NaB4O7•10H2O, 0.4 g CuSO4•5H2O, 1.2 g FeSO4•7H2O, 0.7 g MnSO4•H2O, 0.8 g Na2MoO2•2H2O, 10 g ZnSO4•7H2O, and is made up to 1 liter of deionized water.

[0256] The 50X COVE salt solution consists of the following: 26 g KCl, 26 g MgSO4•7H2O, 76 g KH2PO4, 50 ml COVE trace metal solution, and deionized water to a final volume of 1 liter.

[0257] COVE-sucrose + 10 mM sodium nitrate agar consists of the following: 342.3 g sucrose, 20 ml 50X COVE salt solution, 0.85 g NaNO3, 20 g Noble agar, and 1 liter of deionized water.

[0258] STC buffer consists of the following: 0.8 M sorbitol, 25 mM Tris (pH 8), and 25 mM CaCl2.

[0259] The TAE buffer consists of the following: 4.84 g Tris base, 1.14 ml glacial acetic acid, 2 ml 0.5 M EDTA (pH 8.0), and to a final volume of 1 liter of deionized water.

[0260] The YP culture medium containing 2% glucose consists of the following: 10 g Bacto yeast extract, 20 g Bacto peptone, 20 g glucose, and 1 liter of deionized water.

[0261] The Aspergillus oryzae seed culture medium consists of the following: 18 g yeast extract, 21 g glycerol, 1 ml pranonic acid, 0.6 g urea, and 1 liter of deionized water.

[0262] MDU2-C medium consists of the following: 45 g maltose monohydrate, 1 g MgSO4·7H2O, 1 g NaCl, 2 g K2SO4, 2 g KH2PO4, 2 g urea, 0.5 ml AMG trace elements, and replenished to 1 liter of deionized water.

[0263] Transformation of Aspergillus oryzae

[0264] Transformation of Aspergillus species can be achieved using general methods for yeast transformation. The Aspergillus oryzae host strain was inoculated onto 100 ml of YP + 2% glucose medium supplemented with 10 mM urea and incubated at 30°C and 160 rpm for 16–24 h. The tissue was harvested by filtration, washed with 0.6 M MgSO4, and resuspended in 10 ml of a protoplast solution containing a commercial β-glucanase product (GLUCANEX™, Novozymes A / S, Bagsvær, Denmark) and chitinase (Sigma) at a final concentration of 20 mg / ml. The suspension was incubated at 34°C and 80 rpm until protoplasts formed, then washed twice with STC buffer. The protoplasts were counted using a hemocytometer and resuspended to a final concentration of 2 x 10⁻⁶ cells / ml. 71 protoplast / ml. Add approximately 2 μg of DNA fragment and MAD7 plasmid to 100 µl of protoplast suspension and mix gently. Add approximately 250 μl of polyethylene solution (PEG) to the mixture and mix gently by vortexing. Incubate the protoplast, DNA, and PEG mixture at 37°C for 30 minutes. After incubation, add 1 ml of STC to the transformation mixture and plate it onto a Cove + sucrose + NaNO3 plate, and incubate at 30°C for 7–10 days until colonies appear.

[0265] Aspergillus spores that have been sorted and transformed

[0266] After the colonies formed on the selection plate, spores were collected by immersing the plate in 0.01% Tween-20 and gently scraping it with a spreader. All spores from different plates were collected and combined into a single tube. The individual spores were then sorted into 96-well plates containing Cove + sucrose + NaNO3 using a Sony FACS sorter.

[0267] PCR amplification

[0268] Polymerase chain reaction (PCR) was performed using Phusion hot-start II DNA polymerase (Thermo Fisher Scientific). The PCR reaction mixtures are shown in Table 4 below, and the corresponding PCR cycles are shown in Table 5.

[0269] Table 4. Phusion Hot Start II PCR reaction mixture:

[0270]

[0271] Table 5. Phusion Hot Start II PCR Program

[0272]

[0273] MTP fermentation

[0274] Spores of the selected transformants were inoculated into 0.15 mL of Ao seed medium in 96-well MTP and cultured at 30°C for 2 days. After 2 days, 1 mL of MDU2-C medium was added to each well, and the culture was carried out at 30°C and 350 RPM for 4 days.

[0275] laboratory tank fermentation

[0276] Fermentation was carried out using fed-batch fermentation (H. Pedersen 2000, Appl Microbiol Biotechnol, 53: 272-277). The selected strain was pre-cultured in Ao seed medium, and the resulting mycelium was then transferred to a tank for further culture for protein production. Cultures were maintained at pH 4 to 7 and 30°C to 34°C for 6–8 days, fed with maltodextrin without overfeeding. Yield was evaluated using the supernatant from centrifuged cultures.

[0277] Using aptamer-quantified bovine lactoferrin

[0278] Bovine lactoferrin in the strain was quantified using the aptamers previously published by Zhu C. et al. (Talanta, 2019;205:120088. doi: 10.1016 / j.talanta.2019.06.088. Epub 2019 Jun 27. PMID: 31450439). The supernatant from the MTP assay was used for bovine lactoferrin quantification. Bovine lactoferrin was quantified based on the millipolarization values ​​of the aptamers.

[0279] Quantifying bovine lactoferrin using LabChip® (digital SDS-PAGE)

[0280] • Prepare the supernatant and keep the sample frozen between time points; store in a standard microplate.

[0281] Thaw the sample, then mix it using a wide-bore pipette tip, and then dilute it 10-fold with 1X PBS.

[0282] • Filter the sample using a 0.45 μm PES Millipore 96W filter plate (1000 x g, 10 min, ambient temperature).

[0283] • Set up LabChip sample plates, including blanks (1X PBS) and standard dilution series.

[0284] • Prepare samples according to the high-sensitivity assay recommended by Refitech.

[0285] • Samples were run on LabChip® GXII Touch using the Protein Express 200 high-sensitivity method with parameters of 384w and 4 mm aspiration height.

[0286] • Data were analyzed using smear analysis. A standard curve was fitted in JMP using 4PL, and the titer in the supernatant was determined using a reverse prediction formula.

[0287] The invention described and claimed herein is not limited to the specific aspects disclosed herein, as these aspects are intended to illustrate several aspects of the invention. Any equivalent aspects are intended to be within the scope of the invention. In fact, various modifications to the invention, in addition to those shown and described herein, will become apparent to those skilled in the art from the foregoing description. Such modifications are also intended to fall within the scope of the appended claims. In case of conflict, the disclosure including the definition shall prevail.

[0288] Example List

[0289] The invention is further defined by the following numbered embodiments:

[0290] [1] A nucleic acid construct comprising:

[0291] A first polynucleotide encoding a signal peptide, the signal peptide comprising or consisting of: an amino acid sequence having at least 80% sequence identity with any one of the amino acid sequences of SEQ ID NO: 3, 6, 9 or 11; and

[0292] The second polynucleotide encoding the target polypeptide;

[0293] The first polynucleotide and the second polynucleotide are operatively linked by translational fusion, and the first polynucleotide and the second polynucleotide are heterologous to each other.

[0294] [2] The nucleic acid construct according to Example 1, wherein the second polynucleotide is located downstream of the first polynucleotide.

[0295] [3] The nucleic acid construct according to any one of Examples 1 or 2, wherein the signal peptide is a naturally occurring signal peptide, or a functional fragment or functional variant of a naturally occurring signal peptide.

[0296] [4] The nucleic acid construct according to any one of Examples 1 to 3, wherein the signal peptide is derived from filamentous fungal cells.

[0297] [4a] The nucleic acid construct according to any one of Examples 1 to 4, wherein the first polynucleotide comprises a third polynucleotide.

[0298] [4b] The nucleic acid construct according to any of the foregoing embodiments, wherein the third polynucleotide is a non-coding intron.

[0299] [4c] The nucleic acid construct according to any of the foregoing embodiments, wherein the third polynucleotide has at least 80%, for example at least 85%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% sequence identity with SEQ ID NO:12.

[0300] [5] The nucleic acid construct according to any of the foregoing embodiments, wherein the nucleic acid construct further comprises a heterologous promoter, and wherein the promoter, the first polynucleotide, the second polynucleotide and optionally the third polynucleotide are operatively linked.

[0301] [6] The nucleic acid construct according to any of the foregoing embodiments, wherein the promoter is an amylase promoter, preferably the heterologous promoter is an Aspergillus neutral amylase II promoter, such as the Aspergillus niger neutral amylase II promoter.

[0302] [6a] The nucleic acid construct according to any of the foregoing embodiments, wherein the promoter is a neutral amylase II promoter of Aspergillus niger (Pna2 / tpi) fused with the nontranslational leader sequence of Aspergillus niger triphosphate isomerase.

[0303] [7] The nucleic acid construct according to any of the foregoing embodiments, wherein the promoter is operatively linked to an mRNA stable region; preferably, the mRNA stable region is a cryIIIA mRNA stable region.

[0304] [8] The nucleic acid construct according to any one of the foregoing embodiments, wherein the signal peptide is a naturally occurring signal peptide, or a functional fragment or functional variant of a naturally occurring signal peptide.

[0305] [9] The nucleic acid construct according to any one of the foregoing embodiments, wherein the signal peptide is obtained from a polypeptide expressed by a free Rhizocystis host cell, such as Rhizocystis heterophylla.

[0306] [9a] A nucleic acid construct according to any one of the foregoing embodiments, wherein the signal peptide is obtained from a polypeptide expressed in a free Aspergillus host cell, such as Aspergillus oryzae.

[0307]

[10] The nucleic acid construct according to any one of the foregoing embodiments, wherein the first polynucleotide encoding the signal peptide comprises or is composed of the following: a polynucleotide having at least 80%, for example at least 85%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% sequence identity with the mature polypeptide encoding sequence of SEQ ID NO: 1; most preferably, the first polynucleotide comprises, is substantially composed of, or is composed of the mature polypeptide encoding sequence of SEQ ID NO: 1.

[0308]

[11] The nucleic acid construct according to any one of the foregoing embodiments, wherein the first polynucleotide encoding the signal peptide comprises or is composed of the following: a polynucleotide having at least 80%, for example at least 85%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% sequence identity with the mature polypeptide encoding sequence of SEQ ID NO: 2; most preferably, the first polynucleotide comprises, is substantially composed of, or is composed of the mature polypeptide encoding sequence of SEQ ID NO: 2.

[0309]

[12] The nucleic acid construct according to any one of the foregoing embodiments, wherein the first polynucleotide encoding the signal peptide comprises or is composed of the following: a polynucleotide having at least 80%, for example at least 85%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% sequence identity with the mature polypeptide encoding sequence of SEQ ID NO: 4; most preferably, the first polynucleotide comprises, is substantially composed of, or is composed of the mature polypeptide encoding sequence of SEQ ID NO: 4.

[0310]

[13] The nucleic acid construct according to any one of the foregoing embodiments, wherein the first polynucleotide encoding the signal peptide comprises or is composed of the following: a polynucleotide having at least 80%, for example at least 85%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% sequence identity with the mature polypeptide encoding sequence of SEQ ID NO: 5; most preferably, the first polynucleotide comprises, is substantially composed of, or is composed of the mature polypeptide encoding sequence of SEQ ID NO: 5.

[0311]

[14] The nucleic acid construct according to any one of the foregoing embodiments, wherein the first polynucleotide encoding the signal peptide comprises or is composed of the following: a polynucleotide having at least 80%, for example at least 85%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% sequence identity with the mature polypeptide encoding sequence of SEQ ID NO: 7; most preferably, the first polynucleotide comprises, is substantially composed of, or is composed of the mature polypeptide encoding sequence of SEQ ID NO: 7.

[0312]

[15] The nucleic acid construct according to any one of the foregoing embodiments, wherein the first polynucleotide encoding the signal peptide comprises or is composed of the following: a polynucleotide having at least 80%, for example at least 85%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% sequence identity with the mature polypeptide encoding sequence of SEQ ID NO: 8; most preferably, the first polynucleotide comprises, is substantially composed of, or is composed of the mature polypeptide encoding sequence of SEQ ID NO: 8.

[0313]

[16] The nucleic acid construct according to any one of the foregoing embodiments, wherein the first polynucleotide encoding the signal peptide comprises or is composed of the following: a polynucleotide having at least 80%, for example at least 85%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% sequence identity with the mature polypeptide encoding sequence of SEQ ID NO: 10; most preferably, the first polynucleotide comprises, is substantially composed of, or is composed of the mature polypeptide encoding sequence of SEQ ID NO: 10.

[0314]

[17] The nucleic acid construct according to any one of the foregoing embodiments, wherein the signal peptide is obtained from Rhizocystis cells.

[0315] [17a] The nucleic acid construct according to any one of the foregoing embodiments, wherein the signal peptide is obtained from Heterocystis cells.

[0316]

[18] The nucleic acid construct according to any one of the foregoing embodiments, wherein the signal peptide is obtained from Aspergillus cells.

[0317] [18a] The nucleic acid construct according to any one of the foregoing embodiments, wherein the signal peptide is obtained from Aspergillus oryzae cells.

[0318]

[19] The nucleic acid construct according to any one of the foregoing embodiments, wherein the signal peptide comprises or is composed of the following: an amino acid sequence having at least 80%, for example at least 85%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% sequence identity with SEQ ID NO: 3.

[0319]

[20] The nucleic acid construct according to any one of the foregoing embodiments, wherein the signal peptide comprises SEQ ID NO:3, is substantially composed of, or is composed of.

[0320]

[21] The nucleic acid construct according to any one of the foregoing embodiments, wherein the signal peptide comprises or is composed of the following: an amino acid sequence having at least 80%, for example at least 85%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% sequence identity with SEQ ID NO: 6.

[0321]

[22] The nucleic acid construct according to any one of the foregoing embodiments, wherein the signal peptide comprises, is substantially composed of, or is composed of SEQ ID NO:6.

[0322]

[23] The nucleic acid construct according to any one of the foregoing embodiments, wherein the signal peptide comprises or is composed of the following: an amino acid sequence having at least 80%, for example at least 85%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% sequence identity with SEQ ID NO: 9.

[0323]

[24] The nucleic acid construct according to any one of the foregoing embodiments, wherein the signal peptide comprises, is substantially composed of, or is composed of SEQ ID NO:9.

[0324]

[25] The nucleic acid construct according to any one of the foregoing embodiments, wherein the signal peptide comprises or is composed of the following: an amino acid sequence having at least 80%, for example at least 85%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% sequence identity with SEQ ID NO: 11.

[0325]

[26] The nucleic acid construct according to any one of the foregoing embodiments, wherein the signal peptide comprises, is substantially composed of, or is composed of SEQ ID NO:11.

[0326]

[27] The nucleic acid construct according to any of the foregoing embodiments, wherein the signal peptide consists of an amino acid sequence having or not having a C-terminal alanine of any one of SEQ ID NO: 1, 3, 6, 9 or 11, or a peptide fragment thereof that retains the ability to guide the polypeptide into or across the cell membrane.

[0327]

[28] The nucleic acid construct according to any one of the foregoing embodiments, wherein the N- and / or C-terminus of the signal peptide has been extended by adding one or more amino acids.

[0328]

[29] The nucleic acid construct according to any one of Examples 1 to 28, wherein the signal peptide is a fragment of the signal peptide of any one of Examples 1 to 28.

[0329]

[30] The nucleic acid construct according to any one of the foregoing embodiments, wherein the second polynucleotide encoding the target polypeptide has at least 60%, for example at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% sequence identity with the mature polypeptide encoding sequence of SEQ ID NO:14; most preferably, the second polynucleotide comprises, is substantially composed of, or is composed of the mature polypeptide encoding sequence of SEQ ID NO:14.

[0330]

[31] The nucleic acid construct according to any one of the foregoing embodiments, wherein the target polypeptide is lactoferrin, for example, bovine lactoferrin or human lactoferrin.

[0331] [31a] The nucleic acid construct according to any one of Examples 1-29, wherein the one or more target polypeptides are hydrolases, isomerases, ligases, lyases, oxidoreductases, or transferases, such as α-galactosidase, α-glucosidase, aminopeptidase, amylase, β-galactosidase, β-glucosidase, β-xylosidase, glycosylase, carboxypeptidase, catalase, cellobiase, cellulase, chitinase, keratinase, cyclodextrin glycosyltransferase, deoxyribonuclease, endoglucanase, esterase, glucosylamylase, invertase, laccase, lipase, mannosidase, polysaccharidase, oxidase, pectinase, peroxidase, phytase, polyphenol oxidase, proteolytic enzyme, ribonuclease, transglutaminase, or xylanase.

[0332]

[32] The nucleic acid construct according to any one of the foregoing embodiments, wherein the target polypeptide is bovine lactoferrin.

[0333]

[33] The nucleic acid construct according to any one of the foregoing embodiments, wherein the N- and / or C-terminus of the target polypeptide has been extended by adding one or more amino acids.

[0334]

[34] The nucleic acid construct according to any one of Examples 1 to 33, wherein the target polypeptide is a fragment of the target polypeptide of any one of Examples 1 to 33.

[0335]

[35] An expression vector comprising a nucleic acid construct according to any one of Examples 1 to 34.

[0336]

[36] A fungal host cell, the fungal host cell containing in its genome:

[0337] a) The nucleic acid construct according to any one of Examples 1 to 34; and / or

[0338] b) The expression vector according to Example 35.

[0339]

[37] The host cell according to Example 36, wherein the fungal host cell is a filamentous fungal host cell, such as *Cladosporium*, *Aspergillus*, *Briefomus*, *Cirsium*, *Pseudomonas*, *Aureosporium*, *Coprinus*, *Cladosporium*, *Cryptococcus*, *Ustilago*, *Fusarium*, *Pyrophyllus*, *Pyrophyllus*, *Mucor*, *Pyrophyllus*, *Neurospora*, *Penicillium*, *Penicillium*, *Pseudomonas ... Cells of the genera *Aspergillus*, *Varicella*, *Ruminocyticum*, *Pleurotus*, *Schizophyllum*, *Basilaria*, *Thermophilic Ascomycetes*, *Fusporium*, *Cyclophorus*, *Pterocarya*, or *Trichoderma*, especially *Aspergillus avocado*, *Aspergillus sulphureus*, *Aspergillus fumigatus*, *Aspergillus japonicus*, *Aspergillus nidus*, *Aspergillus oryzae*, *Aspergillus niger*, *Aspergillus oryzae*, *Pterocarya nidus*, *Pterocarya carnegiea*, *Pterocarya pallens*, *Pterocarya pannohita*, *Pterocarya circinata*, *Pterocarya scabra*, and *Pterocarya scabra*. *Cephalomyces*, *Aureobasidium stenoptera*, *Aureobasidium keratophilum*, *Aureobasidium ruthenicum*, *Aureobasidium fecalithum*, *Aureobasidium monnieri*, *Aureobasidium queensii*, *Aureobasidium tropicalis*, *Aureobasidium brevicornu*, *Coprinus comatus*, *Aureobasidium triflorum*, *Fusarium moniliforme ... Fusarium scabiosifolium, Fusarium pseudocranioides, Fusarium sulfideum, Fusarium rotundum, Fusarium pseudofilariae, Fusarium variegatum, specific humic mold, loose cottony humic mold, Rhizopus spp., thermophilic filamentous mold, Neurospora crassa, Penicillium purpureum, Chlorella vulgaris, Radiata spp., Pleurotus eryngii, Emersonia spp., Clostridium terreum, Trichoderma harzianum, Trichoderma koningii, Trichoderma longifolium, Trichoderma reesei, or green Trichoderma cells.

[0340]

[38] The host cell according to any one of Examples 36 to 37, wherein the host cell is an Aspergillus cell.

[0341]

[39] The host cell according to any one of Examples 36 to 38, wherein the host cell is a *Aspergillus niger* or *Aspergillus oryzae* host cell.

[0342]

[40] The host cell according to any one of Examples 36 to 39, wherein the host cell contains at least two copies of the nucleic acid construct and / or the expression vector, such as two copies, three copies, four copies or more than four copies.

[0343]

[41] A method for generating a target polypeptide, the method comprising:

[0344] a) Culture the host cells according to any one of Examples 36 to 40 under conditions conducive to the production of the target polypeptide; and optionally...

[0345] b) Recover the target polypeptide.

[0346]

[42] A fusion polypeptide comprising

[0347] a) a signal peptide comprising or consisting of: an amino acid sequence having at least 60% sequence identity with any one of SEQ ID NO: 1, 3, 6, 9 or 11, and

[0348] b) Target polypeptide.

[0349]

[43] The fusion polypeptide according to Example 42, wherein the target polypeptide comprises a lactoferrin polypeptide comprising, or being composed of, an amino acid sequence having at least 60% sequence identity with SEQ ID NO: 13.

[0350]

[44] The fusion polypeptide according to any one of Examples 42-43, wherein the signal peptide is located upstream of the target polypeptide.

[0351]

[45] The fusion polypeptide according to any one of Examples 42 to 44, wherein the signal peptide is located at the N-terminus of the target polypeptide.

[0352]

[46] The fusion polypeptide according to any one of Examples 42 to 45, wherein the lactoferrin polypeptide is selected from the group consisting of:

[0353] (a) A polypeptide having at least 60% sequence identity with SEQ ID NO: 13;

[0354] (b) A polypeptide encoded by a polynucleotide having at least 60% sequence identity with the mature polypeptide encoding sequence of SEQ ID NO: 14;

[0355] (c) A polypeptide derived from SEQ ID NO: 13 by having 1 to 30 alterations (e.g., substitution, deletion and / or insertion) at one or more locations, such as 1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 or 9 or 10 or 11 or 12 or 13 or 14 or 15 or 16 or 17 or 18 or 19 or 20 or 21 or 22 or 23 or 24 or 25 or 26 or 27 or 28 or 29 or 30 alterations, particularly substitutions;

[0356] (d) A polypeptide derived from (a), (b) or (c) wherein the N-terminus and / or C-terminus have been extended by adding one or more amino acids;

[0357] Fragments of polypeptides of (e), (a), (b), (c), or (d), and

[0358] (f)(e) fragments, wherein the polypeptide has 1-10 deletions at the N-terminus.

Claims

1. A nucleic acid construct comprising: A first polynucleotide encoding a signal peptide, the signal peptide comprising or consisting of: an amino acid sequence having at least 80% sequence identity with any one of the amino acid sequences of SEQ ID NO: 3, 6, 9 or 11; and The second polynucleotide encoding the target polypeptide; The first polynucleotide and the second polynucleotide are operatively linked by translational fusion, and the first polynucleotide and the second polynucleotide are heterologous to each other.

2. The nucleic acid construct of claim 1, wherein the signal peptide comprises or consists of: An amino acid sequence having at least 85%, such as at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% sequence identity with any of the amino acid sequences of SEQ IDNO: 3, 6, 9, or 11.

3. The nucleic acid construct of any one of the preceding claims, wherein the first polynucleotide comprises or consists of: A polynucleotide having at least 85%, such as at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% sequence identity with any of SEQ ID NO: 1, 2, 4, 5, 7, 8, or 100%.

4. The nucleic acid construct according to any one of the preceding claims, wherein the target polypeptide comprises or is composed of a lactoferrin polypeptide.

5. The nucleic acid construct according to any one of the preceding claims, wherein the polypeptide of interest comprises or consists of: An amino acid sequence having at least 85%, such as at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% sequence identity with SEQ ID NO:

13.

6. An expression vector comprising a nucleic acid construct according to any one of claims 1 to 5.

7. A fungal host cell, the fungal host cell containing in its genome: a) The nucleic acid construct according to any one of claims 1 to 5; and / or b) The expression vector according to claim 6.

8. The fungal host cell according to claim 7, wherein the fungal host cell is a filamentous fungal host cell, such as *Cladosporium*, *Aspergillus*, *Briefomus*, *Cirsium*, *Pseudomonas*, *Aureospora*, *Coprinus*, *Cladosporium*, *Cryptococcus*, *Ustilago*, *Fusarium*, *Pyrophyllus*, *Mucor*, *Hydrophyllus*, *Neurospora*, *Penicillium*, *Penicillium*, *Pseudomonas ... Cells of the genera *Aspergillus*, *Varicella*, *Ruminocyticum*, *Pleurotus*, *Schizophyllum*, *Basilaria*, *Thermophilic Ascomycetes*, *Fusporium*, *Cyclophorus*, *Pterygophyllum*, or *Trichoderma*, especially *Aspergillus avocado*, *Aspergillus sulphureus*, *Aspergillus fumigatus*, *Aspergillus japonicus*, *Aspergillus nidus*, *Aspergillus oryzae*, *Aspergillus niger*, *Aspergillus oryzae*, *Pterygophyllum nidus*, *Pterygophyllum carnegieum*, *Pterygophyllum pallens*, *Pterygophyllum pannohita*, *Pterygophyllum circumferentiale*, *Pterygophyllum microcarneae*, and *Pterygophyllum spp.* *Cephalomyces*, *Aureobasidium stenoptera*, *Aureobasidium keratophilum*, *Aureobasidium ruthenicum*, *Aureobasidium fecalithum*, *Aureobasidium monnieri*, *Aureobasidium queensii*, *Aureobasidium tropicalis*, *Aureobasidium brevicornu*, *Coprinus comatus*, *Aureobasidium triflorum*, *Fusarium moniliforme ... Fusarium scabiosifolium, Fusarium pseudocranioides, Fusarium sulfideum, Fusarium rotundum, Fusarium pseudofilariae, Fusarium variegatum, specific humic mold, loose cottony humic mold, Rhizopus spp., thermophilic filamentous mold, Neurospora crassa, Penicillium purpureum, Chlorella vulgaris, Radiata spp., Pleurotus eryngii, Emersonia spp., Clostridium terreum, Trichoderma harzianum, Trichoderma koningii, Trichoderma longifolium, Trichoderma reesei, or green Trichoderma cells.

9. The fungal host cell according to any one of claims 7-8, wherein the cell is an Aspergillus cell, for example, Aspergillus niger cells or Aspergillus oryzae cells.

10. A method for generating a target polypeptide, the method comprising: a) Culture the host cell according to any one of claims 7-9 under conditions conducive to the production of the target polypeptide; and optional b) Recover the target polypeptide.

11. The method of claim 10, wherein the target polypeptide comprises or is composed of lactoferrin polypeptide.

12. A fusion polypeptide comprising: A signal peptide comprising or consisting of: an amino acid sequence having at least 60%, for example at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% sequence identity with any of SEQ ID NO: 3, 6, 9, or 11; and A lactoferricin polypeptide comprising or consisting of: An amino acid sequence having at least 60%, such as at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% sequence identity with SEQ ID NO: 13.

Citation Information

Patent Citations

  • Process for the production of protein products in Aspergillus oryzae and a promoter for use in Aspergillus

    EP0238023A2

  • Directed evolution of novel binding proteins

    US5223409A

  • A method for killing cells without cell lysis

    WO1990015861A1

  • Surface expression libraries of heteromeric receptors

    WO1992006204A1

  • Nucleotide sequences for the control of the expression of DNA sequences in a cellular host

    WO1994025612A2